- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-16-mer
- Ligands
- 16 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.3: 15 residues within 4Å:- Chain A: I.162, S.164, S.165, R.166, D.167, T.185, D.189, L.190, V.191, K.211, G.212, K.213
- Chain K: R.166
- Ligands: GTP.1, ATP.28
12 PLIP interactions:1 interactions with chain K, 11 interactions with chain A- Salt bridges: K:R.166, A:R.166, A:R.166, A:R.166
- Hydrogen bonds: A:S.164, A:S.165, A:S.165, A:S.165, A:R.166, A:V.191, A:K.213, A:K.213
ATP.8: 15 residues within 4Å:- Chain C: I.162, S.164, S.165, R.166, D.167, T.185, D.189, L.190, V.191, K.211, G.212, K.213
- Chain I: R.166
- Ligands: GTP.6, ATP.23
12 PLIP interactions:1 interactions with chain I, 11 interactions with chain C- Salt bridges: I:R.166, C:R.166, C:R.166, C:R.166
- Hydrogen bonds: C:S.164, C:S.165, C:S.165, C:S.165, C:R.166, C:V.191, C:K.213, C:K.213
ATP.13: 15 residues within 4Å:- Chain E: I.162, S.164, S.165, R.166, D.167, T.185, D.189, L.190, V.191, K.211, G.212, K.213
- Chain O: R.166
- Ligands: GTP.11, ATP.38
12 PLIP interactions:11 interactions with chain E, 1 interactions with chain O- Hydrogen bonds: E:S.164, E:S.165, E:S.165, E:S.165, E:R.166, E:V.191, E:K.213, E:K.213
- Salt bridges: E:R.166, E:R.166, E:R.166, O:R.166
ATP.18: 15 residues within 4Å:- Chain G: I.162, S.164, S.165, R.166, D.167, T.185, D.189, L.190, V.191, K.211, G.212, K.213
- Chain M: R.166
- Ligands: GTP.16, ATP.33
12 PLIP interactions:11 interactions with chain G, 1 interactions with chain M- Hydrogen bonds: G:S.164, G:S.165, G:S.165, G:S.165, G:R.166, G:V.191, G:K.213, G:K.213
- Salt bridges: G:R.166, G:R.166, G:R.166, M:R.166
ATP.23: 15 residues within 4Å:- Chain C: R.166
- Chain I: I.162, S.164, S.165, R.166, D.167, T.185, D.189, L.190, V.191, K.211, G.212, K.213
- Ligands: ATP.8, GTP.21
12 PLIP interactions:11 interactions with chain I, 1 interactions with chain C- Hydrogen bonds: I:S.164, I:S.165, I:S.165, I:S.165, I:R.166, I:V.191, I:K.213, I:K.213
- Salt bridges: I:R.166, I:R.166, I:R.166, C:R.166
ATP.28: 15 residues within 4Å:- Chain A: R.166
- Chain K: I.162, S.164, S.165, R.166, D.167, T.185, D.189, L.190, V.191, K.211, G.212, K.213
- Ligands: ATP.3, GTP.26
12 PLIP interactions:11 interactions with chain K, 1 interactions with chain A- Hydrogen bonds: K:S.164, K:S.165, K:S.165, K:S.165, K:R.166, K:V.191, K:K.213, K:K.213
- Salt bridges: K:R.166, K:R.166, K:R.166, A:R.166
ATP.33: 15 residues within 4Å:- Chain G: R.166
- Chain M: I.162, S.164, S.165, R.166, D.167, T.185, D.189, L.190, V.191, K.211, G.212, K.213
- Ligands: ATP.18, GTP.31
12 PLIP interactions:11 interactions with chain M, 1 interactions with chain G- Hydrogen bonds: M:S.164, M:S.165, M:S.165, M:S.165, M:R.166, M:V.191, M:K.213, M:K.213
- Salt bridges: M:R.166, M:R.166, M:R.166, G:R.166
ATP.38: 15 residues within 4Å:- Chain E: R.166
- Chain O: I.162, S.164, S.165, R.166, D.167, T.185, D.189, L.190, V.191, K.211, G.212, K.213
- Ligands: ATP.13, GTP.36
12 PLIP interactions:11 interactions with chain O, 1 interactions with chain E- Hydrogen bonds: O:S.164, O:S.165, O:S.165, O:S.165, O:R.166, O:V.191, O:K.213, O:K.213
- Salt bridges: O:R.166, O:R.166, O:R.166, E:R.166
- 8 x IMP: INOSINIC ACID(Covalent)
IMP.4: 20 residues within 4Å:- Chain A: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.5
12 PLIP interactions:12 interactions with chain A- Hydrogen bonds: A:R.327, A:S.334, A:S.334, A:D.369, A:G.371, A:G.392, A:S.393, A:S.393, A:M.419, A:G.420, A:S.421, A:Q.446
IMP.9: 20 residues within 4Å:- Chain C: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.10
12 PLIP interactions:12 interactions with chain C- Hydrogen bonds: C:R.327, C:S.334, C:S.334, C:D.369, C:G.371, C:G.392, C:S.393, C:S.393, C:M.419, C:G.420, C:S.421, C:Q.446
IMP.14: 20 residues within 4Å:- Chain E: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.15
12 PLIP interactions:12 interactions with chain E- Hydrogen bonds: E:R.327, E:S.334, E:S.334, E:D.369, E:G.371, E:G.392, E:S.393, E:S.393, E:M.419, E:G.420, E:S.421, E:Q.446
IMP.19: 20 residues within 4Å:- Chain G: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.20
12 PLIP interactions:12 interactions with chain G- Hydrogen bonds: G:R.327, G:S.334, G:S.334, G:D.369, G:G.371, G:G.392, G:S.393, G:S.393, G:M.419, G:G.420, G:S.421, G:Q.446
IMP.24: 20 residues within 4Å:- Chain I: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.25
13 PLIP interactions:13 interactions with chain I- Hydrogen bonds: I:R.327, I:S.334, I:D.369, I:G.371, I:G.392, I:S.393, I:S.393, I:S.393, I:Y.416, I:M.419, I:G.420, I:S.421, I:Q.446
IMP.29: 20 residues within 4Å:- Chain K: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.30
13 PLIP interactions:13 interactions with chain K- Hydrogen bonds: K:R.327, K:S.334, K:D.369, K:G.371, K:G.392, K:S.393, K:S.393, K:S.393, K:Y.416, K:M.419, K:G.420, K:S.421, K:Q.446
IMP.34: 20 residues within 4Å:- Chain M: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.35
13 PLIP interactions:13 interactions with chain M- Hydrogen bonds: M:R.327, M:S.334, M:D.369, M:G.371, M:G.392, M:S.393, M:S.393, M:S.393, M:Y.416, M:M.419, M:G.420, M:S.421, M:Q.446
IMP.39: 20 residues within 4Å:- Chain O: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.40
13 PLIP interactions:13 interactions with chain O- Hydrogen bonds: O:R.327, O:S.334, O:D.369, O:G.371, O:G.392, O:S.393, O:S.393, O:S.393, O:Y.416, O:M.419, O:G.420, O:S.421, O:Q.446
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.5: 17 residues within 4Å:- Chain A: H.98, T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, M.419, G.420, Q.446
- Chain G: Q.474
- Ligands: IMP.4
16 PLIP interactions:15 interactions with chain A, 1 interactions with chain G- Hydrogen bonds: A:H.98, A:T.257, A:H.258, A:E.259, A:E.259, A:D.279, A:S.281, A:N.308, A:G.329, A:G.331, G:Q.474
- Salt bridges: A:H.258
- pi-Stacking: A:F.287, A:F.287
- pi-Cation interactions: A:H.258, A:H.258
NAD.10: 17 residues within 4Å:- Chain A: Q.474
- Chain C: H.98, T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, M.419, G.420, Q.446
- Ligands: IMP.9
16 PLIP interactions:15 interactions with chain C, 1 interactions with chain A- Hydrogen bonds: C:H.98, C:T.257, C:H.258, C:E.259, C:E.259, C:D.279, C:S.281, C:N.308, C:G.329, C:G.331, A:Q.474
- Salt bridges: C:H.258
- pi-Stacking: C:F.287, C:F.287
- pi-Cation interactions: C:H.258, C:H.258
NAD.15: 17 residues within 4Å:- Chain C: Q.474
- Chain E: H.98, T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, M.419, G.420, Q.446
- Ligands: IMP.14
16 PLIP interactions:1 interactions with chain C, 15 interactions with chain E- Hydrogen bonds: C:Q.474, E:H.98, E:T.257, E:H.258, E:E.259, E:E.259, E:D.279, E:S.281, E:N.308, E:G.329, E:G.331
- Salt bridges: E:H.258
- pi-Stacking: E:F.287, E:F.287
- pi-Cation interactions: E:H.258, E:H.258
NAD.20: 17 residues within 4Å:- Chain E: Q.474
- Chain G: H.98, T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, M.419, G.420, Q.446
- Ligands: IMP.19
16 PLIP interactions:15 interactions with chain G, 1 interactions with chain E- Hydrogen bonds: G:H.98, G:T.257, G:H.258, G:E.259, G:E.259, G:D.279, G:S.281, G:N.308, G:G.329, G:G.331, E:Q.474
- Salt bridges: G:H.258
- pi-Stacking: G:F.287, G:F.287
- pi-Cation interactions: G:H.258, G:H.258
NAD.25: 17 residues within 4Å:- Chain I: H.98, T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, M.419, G.420, Q.446
- Chain O: Q.474
- Ligands: IMP.24
14 PLIP interactions:13 interactions with chain I, 1 interactions with chain O- Hydrogen bonds: I:H.98, I:T.257, I:E.259, I:D.279, I:S.281, I:N.308, I:G.329, I:G.331, O:Q.474
- Salt bridges: I:H.258
- pi-Stacking: I:F.287, I:F.287
- pi-Cation interactions: I:H.258, I:H.258
NAD.30: 17 residues within 4Å:- Chain I: Q.474
- Chain K: H.98, T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, M.419, G.420, Q.446
- Ligands: IMP.29
14 PLIP interactions:13 interactions with chain K, 1 interactions with chain I- Hydrogen bonds: K:H.98, K:T.257, K:E.259, K:D.279, K:S.281, K:N.308, K:G.329, K:G.331, I:Q.474
- Salt bridges: K:H.258
- pi-Stacking: K:F.287, K:F.287
- pi-Cation interactions: K:H.258, K:H.258
NAD.35: 17 residues within 4Å:- Chain K: Q.474
- Chain M: H.98, T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, M.419, G.420, Q.446
- Ligands: IMP.34
14 PLIP interactions:13 interactions with chain M, 1 interactions with chain K- Hydrogen bonds: M:H.98, M:T.257, M:E.259, M:D.279, M:S.281, M:N.308, M:G.329, M:G.331, K:Q.474
- Salt bridges: M:H.258
- pi-Stacking: M:F.287, M:F.287
- pi-Cation interactions: M:H.258, M:H.258
NAD.40: 17 residues within 4Å:- Chain M: Q.474
- Chain O: H.98, T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, M.419, G.420, Q.446
- Ligands: IMP.39
14 PLIP interactions:13 interactions with chain O, 1 interactions with chain M- Hydrogen bonds: O:H.98, O:T.257, O:E.259, O:D.279, O:S.281, O:N.308, O:G.329, O:G.331, M:Q.474
- Salt bridges: O:H.258
- pi-Stacking: O:F.287, O:F.287
- pi-Cation interactions: O:H.258, O:H.258
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Johnson, M.C. et al., Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation. Elife (2020)
- Release Date
- 2020-03-25
- Peptides
- Inosine-5'-monophosphate dehydrogenase 2: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
IC
BD
JE
CF
KG
DH
LI
EJ
MK
FL
NM
GN
OO
HP
P
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-16-mer
- Ligands
- 16 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 8 x IMP: INOSINIC ACID(Covalent)
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Johnson, M.C. et al., Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation. Elife (2020)
- Release Date
- 2020-03-25
- Peptides
- Inosine-5'-monophosphate dehydrogenase 2: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
IC
BD
JE
CF
KG
DH
LI
EJ
MK
FL
NM
GN
OO
HP
P